Intas Pharmaceuticals Ltd., of Ahmedabad, India, received an ex parte injunction from the Delhi High Court against the sale of the anti-epilepsy drug, Valrope, by Arinna Lifesciences Pvt. Ltd., also of Ahmedabad. Intas accused Arinna of a trademark violation against its brand, Valprol.